ArticleJournal of clinical medicine2025

Virologic Response at 12 Months Predicts Lower Hepatocellular Carcinoma Risk in Genotype D Chronic Hepatitis B Patients Treated with Nucleos(t)ide Analogues.

Oguzhan Ozturk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.